| # | Title | Journal | Year | Citations |
|---|
| 1 | MicroRNAs in the Human Heart | Circulation | 2007 | 852 |
| 2 | European Society of Endocrinology Clinical Practice Guidelines on the management of adrenocortical carcinoma in adults, in collaboration with the European Network for the Study of Adrenal Tumors | European Journal of Endocrinology | 2018 | 559 |
| 3 | Activation of CD4 + T Lymphocytes Improves Wound Healing and Survival After Experimental Myocardial Infarction in Mice | Circulation | 2012 | 393 |
| 4 | Adrenocortical carcinoma: a clinician's update | Nature Reviews Endocrinology | 2011 | 336 |
| 5 | Clinical management of adrenocortical carcinoma | Best Practice and Research in Clinical Endocrinology and Metabolism | 2009 | 272 |
| 6 | Complementary and Incremental Mortality Risk Prediction by Cortisol and Aldosterone in Chronic Heart Failure | Circulation | 2007 | 262 |
| 7 | Efficacy of Adjuvant Radiotherapy of the Tumor Bed on Local Recurrence of Adrenocortical Carcinoma | Journal of Clinical Endocrinology and Metabolism | 2006 | 224 |
| 8 | The variation of morphological and functional cardiac manifestation in Fabry disease: potential implications for the time course of the disease | European Heart Journal | 2005 | 214 |
| 9 | Role of Lymphocytes in Myocardial Injury, Healing, and Remodeling After Myocardial Infarction | Circulation Research | 2015 | 212 |
| 10 | Adrenocortical carcinomas and malignant phaeochromocytomas: ESMO–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up | Annals of Oncology | 2020 | 209 |
| 11 | Prognostic factors in stage III–IV adrenocortical carcinomas (ACC): an European Network for the Study of Adrenal Tumor (ENSAT) study | Annals of Oncology | 2015 | 196 |
| 12 | Genetics, diagnosis, management and future directions of research of phaeochromocytoma and paraganglioma: a position statement and consensus of the Working Group on Endocrine Hypertension of the European Society of Hypertension | Journal of Hypertension | 2020 | 190 |
| 13 | Chronic nonbacterial osteomyelitis in childhood: prospective follow-up during the first year of anti-inflammatory treatment | Arthritis Research and Therapy | 2010 | 171 |
| 14 | Dietary Protein Sources and Risk for Incident Chronic Kidney Disease: Results From the Atherosclerosis Risk in Communities (ARIC) Study | Arthritis Research and Therapy | 2017 | 165 |
| 15 | Monocytes/macrophages prevent healing defects and left ventricular thrombus formation after myocardial infarction | FASEB Journal | 2013 | 160 |
| 16 | Differences in Fabry Cardiomyopathy Between Female and Male Patients | JACC: Cardiovascular Imaging | 2011 | 157 |
| 17 | Improved Survival in Patients with Stage II Adrenocortical Carcinoma Followed Up Prospectively by Specialized Centers | Journal of Clinical Endocrinology and Metabolism | 2010 | 150 |
| 18 | Sunitinib in Refractory Adrenocortical Carcinoma: A Phase II, Single-Arm, Open-Label Trial | Journal of Clinical Endocrinology and Metabolism | 2012 | 146 |
| 19 | Clinical implication of mitral annular plane systolic excursion for patients with cardiovascular disease | European Heart Journal Cardiovascular Imaging | 2013 | 145 |
| 20 | Left ventricular remodelling post-myocardial infarction: pathophysiology, imaging, and novel therapies | European Heart Journal | 2022 | 136 |
| 21 | "GOLD or lower limit of normal definition? a comparison with expert-based diagnosis of chronic obstructive pulmonary disease in a prospective cohort-study" | Respiratory Research | 2012 | 134 |
| 22 | The Role of Surgery in the Management of Recurrent Adrenocortical Carcinoma | Journal of Clinical Endocrinology and Metabolism | 2013 | 132 |
| 23 | Urine steroid metabolomics for the differential diagnosis of adrenal incidentalomas in the EURINE-ACT study: a prospective test validation study | Lancet Diabetes and Endocrinology,the | 2020 | 129 |
| 24 | The German Chronic Kidney Disease (GCKD) study: design and methods | Nephrology Dialysis Transplantation | 2012 | 127 |
| 25 | Bevacizumab plus capecitabine as a salvage therapy in advanced adrenocortical carcinoma | European Journal of Endocrinology | 2010 | 119 |
| 26 | Pathophysiology of isoprostanes in the cardiovascular system: implications of isoprostane‐mediated thromboxane A2 receptor activation | British Journal of Pharmacology | 2014 | 119 |
| 27 | Cardiovascular Disease and Cognitive Decline in Postmenopausal Women: Results From the Women's Health Initiative Memory Study | Journal of the American Heart Association | 2013 | 118 |
| 28 | Relation of Burden of Myocardial Fibrosis to Malignant Ventricular Arrhythmias and Outcomes in Fabry Disease | American Journal of Cardiology | 2014 | 112 |
| 29 | Risk-adapted postremission therapy in acute myeloid leukemia: results of the german multicenter AML HD93 treatment trial | Leukemia | 2003 | 110 |
| 30 | Drug interactions with mitotane by induction of CYP3A4 metabolism in the clinical management of adrenocortical carcinoma | Clinical Endocrinology | 2011 | 110 |
| 31 | Mifepristone (RU 486) in Cushing's syndrome | European Journal of Endocrinology | 2007 | 108 |
| 32 | Long-Term Outcomes of Adjuvant Mitotane Therapy in Patients With Radically Resected Adrenocortical Carcinoma | Journal of Clinical Endocrinology and Metabolism | 2017 | 108 |
| 33 | The risk of cardiovascular events with increased apolipoprotein CIII: A systematic review and meta-analysis | Journal of Clinical Lipidology | 2015 | 106 |
| 34 | Mitotane Monotherapy in Patients With Advanced Adrenocortical Carcinoma | Journal of Clinical Endocrinology and Metabolism | 2018 | 105 |
| 35 | Dietary Patterns and Fractures in Postmenopausal Women | JAMA Internal Medicine | 2016 | 102 |
| 36 | Contribution of comorbidities to functional impairment is higher in heart failure with preserved than with reduced ejection fraction | Clinical Research in Cardiology | 2011 | 101 |
| 37 | New targets and therapeutic approaches for endocrine malignancies☆ | Clinical Research in Cardiology | 2009 | 97 |
| 38 | CT Characteristics of Pheochromocytoma: Relevance for the Evaluation of Adrenal Incidentaloma | Journal of Clinical Endocrinology and Metabolism | 2019 | 96 |
| 39 | Contemporary Management of Adrenocortical Carcinoma | European Urology | 2011 | 92 |
| 40 | Conditional Neuronal Nitric Oxide Synthase Overexpression Impairs Myocardial Contractility | Circulation Research | 2007 | 90 |
| 41 | TP53Germline Mutations in Adult Patients with Adrenocortical Carcinoma | Journal of Clinical Endocrinology and Metabolism | 2012 | 89 |
| 42 | Depression and Disease Severity as Predictors of Health-Related Quality of Life in Patients With Chronic Heart Failure—A Structural Equation Modeling Approach | Journal of Cardiac Failure | 2009 | 82 |
| 43 | Cardiomyopathy of Friedreich Ataxia | Journal of Neurochemistry | 2013 | 82 |
| 44 | Artificially Sweetened Beverages and Stroke, Coronary Heart Disease, and All-Cause Mortality in the Women’s Health Initiative | Stroke | 2019 | 82 |
| 45 | Exquisite sensitivity of adrenocortical carcinomas to induction of ferroptosis | Proceedings of the National Academy of Sciences of the United States of America | 2019 | 81 |
| 46 | Vitamin D testing: advantages and limits of the current assays | European Journal of Clinical Nutrition | 2020 | 81 |
| 47 | Gemcitabine-Based Chemotherapy in Adrenocortical Carcinoma: A Multicenter Study of Efficacy and Predictive Factors | Journal of Clinical Endocrinology and Metabolism | 2017 | 79 |
| 48 | Protective effects of sphingosine-1-phosphate receptor agonist treatment after myocardial ischaemia–reperfusion | Cardiovascular Research | 2009 | 73 |
| 49 | [131I]Iodometomidate for Targeted Radionuclide Therapy of Advanced Adrenocortical Carcinoma | Journal of Clinical Endocrinology and Metabolism | 2012 | 70 |
| 50 | Dietary Protein Intake and Coronary Heart Disease in a Large Community Based Cohort: Results from the Atherosclerosis Risk in Communities (ARIC) Study | PLoS ONE | 2014 | 70 |
